Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2016

Open Access 01-12-2016 | Research article

Lung functions among patients with pulmonary tuberculosis in Dar es Salaam – a cross-sectional study

Authors: Mohamed Manji, Grace Shayo, Simon Mamuya, Rose Mpembeni, Ahmed Jusabani, Ferdinand Mugusi

Published in: BMC Pulmonary Medicine | Issue 1/2016

Login to get access

Abstract

Background

Approximately 40–60 % of patients remain sufferers of sequela of obstructive, restrictive or mixed patterns of lung disease despite treatment for pulmonary tuberculosis (PTB). The prevalence of these abnormalities in Tanzania remains unknown.

Methods

A descriptive cross-sectional study was carried out among 501 patients with PTB who had completed at least 20 weeks of treatment. These underwent spirometry and their lung functions were classified as normal or abnormal (obstructive, restrictive or mixed). Logistic regression models were used to explore factors associated with abnormal lung functions.

Results

Abnormal lung functions were present in 371 (74 %) patients. There were 210 (42 %) patients with obstructive, 65 (13 %) patients with restrictive and 96 (19 %) patients with mixed patterns respectively. Significant factors associated with abnormal lung functions included recurrent PTB (Adj OR 2.8, CI 1.274 - 6.106), Human Immunodeficiency Virus (HIV) negative status (Adj OR 1.7, CI 1.055 - 2.583), age more than 40 years (Adj OR 1.7, CI 1.080 - 2.804) and male sex (Adj OR 1.7, CI 1.123 - 2.614).

Conclusion

The prevalence of abnormal lung functions is high and it is associated with male sex, age older than 40 years, recurrent PTB and HIV negative status.
Literature
1.
go back to reference WHO. The Global Burden of Disease 2004 Update. WHO. 2008. WHO. The Global Burden of Disease 2004 Update. WHO. 2008.
2.
3.
go back to reference Snider G, Doctor L, Demas T, Shaw A. Obstructive airway disease in patients with treated pulmonary tuberculosis. Am Rev Respir Dis. 1971;103(5):625–40.PubMed Snider G, Doctor L, Demas T, Shaw A. Obstructive airway disease in patients with treated pulmonary tuberculosis. Am Rev Respir Dis. 1971;103(5):625–40.PubMed
4.
go back to reference Birath G, Caro J, Malmberg R, Simonsson BG. Airways obstruction in pulmonary tuberculosis. Scand J Respir Dis. 1966;47:27–36.PubMed Birath G, Caro J, Malmberg R, Simonsson BG. Airways obstruction in pulmonary tuberculosis. Scand J Respir Dis. 1966;47:27–36.PubMed
5.
go back to reference Lancaster JF, Tomashefski JF. Tuberculosis--a cause of emphysema. Am Rev Respir Dis. 1963;87:435–7.CrossRefPubMed Lancaster JF, Tomashefski JF. Tuberculosis--a cause of emphysema. Am Rev Respir Dis. 1963;87:435–7.CrossRefPubMed
6.
go back to reference Plit ML, Anderson R, Van Rensburg CE, Page-Shipp L, Blott JA, Fresen JL, Feldman C. Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis. Eur Respir J. 1998;12:351–6.CrossRefPubMed Plit ML, Anderson R, Van Rensburg CE, Page-Shipp L, Blott JA, Fresen JL, Feldman C. Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis. Eur Respir J. 1998;12:351–6.CrossRefPubMed
7.
go back to reference Simpson DG, Uschner M, Mcclement J. Respiratory function in pulmonary tuberculosis. Am Rev Respir Dis. 1963;87:1–16.PubMed Simpson DG, Uschner M, Mcclement J. Respiratory function in pulmonary tuberculosis. Am Rev Respir Dis. 1963;87:1–16.PubMed
8.
go back to reference Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax. 2000;55:32–8.CrossRefPubMedPubMedCentral Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax. 2000;55:32–8.CrossRefPubMedPubMedCentral
9.
go back to reference Willcox PA, Ferguson AD. Chronic obstructive airways disease following treated pulmonary tuberculosis. Respir Med. 1989;83:195–8.CrossRefPubMed Willcox PA, Ferguson AD. Chronic obstructive airways disease following treated pulmonary tuberculosis. Respir Med. 1989;83:195–8.CrossRefPubMed
10.
go back to reference Krishna K, Bond S, Artvinli M, Reid KDG, McHardy GJR, Crofton JW. Pulmonary function in treated tuberculosis; a long-term follow-up. Am Rev Respir Dis. 1977;115:402–4. Krishna K, Bond S, Artvinli M, Reid KDG, McHardy GJR, Crofton JW. Pulmonary function in treated tuberculosis; a long-term follow-up. Am Rev Respir Dis. 1977;115:402–4.
11.
go back to reference Vargha G. Fifteen year follow-up of lung function in obstructive and non-obstructive pulmonary tuberculosis. Acta Med Hung. 1983;40:271–6.PubMed Vargha G. Fifteen year follow-up of lung function in obstructive and non-obstructive pulmonary tuberculosis. Acta Med Hung. 1983;40:271–6.PubMed
12.
go back to reference Seaton A, LA Seaton D. Crofton and Douglass’s Respiratory Disease. United Kingdom: Blackwell Science; 2002. Seaton A, LA Seaton D. Crofton and Douglass’s Respiratory Disease. United Kingdom: Blackwell Science; 2002.
13.
go back to reference WHO. Global Tuberculosis Report 2015. 2015. WHO. Global Tuberculosis Report 2015. 2015.
14.
go back to reference The First National Tuberculosis Prevalence Survey in the United Republic of Tanzania Final Report. 2013. The First National Tuberculosis Prevalence Survey in the United Republic of Tanzania Final Report. 2013.
15.
go back to reference Stenton C. The MRC breathlessness scale. Occup Med (Lond). 2008;58:226–7.CrossRef Stenton C. The MRC breathlessness scale. Occup Med (Lond). 2008;58:226–7.CrossRef
16.
go back to reference Walters JAE, Wood-baker R, Walls J, Johns DP. Stability of the EasyOne ultrasonic spirometer for use in general practice. 2006. p. 306–10. Walters JAE, Wood-baker R, Walls J, Johns DP. Stability of the EasyOne ultrasonic spirometer for use in general practice. 2006. p. 306–10.
17.
go back to reference Skloot GS, Edwards NT, Enright PL. Four-Year Calibration Stability of the EasyOne Portable Spirometer. Respir Care. 2010;55:873–7.PubMed Skloot GS, Edwards NT, Enright PL. Four-Year Calibration Stability of the EasyOne Portable Spirometer. Respir Care. 2010;55:873–7.PubMed
18.
go back to reference Barr RG, Stemple KJ, Mesia-vela S, Basner C, Derk S, Henneberger P, Milton DK, Taveras B. Reproducibility and Validity of a Handheld Spirometer. Respir Care. 2008;53:433–41.PubMedPubMedCentral Barr RG, Stemple KJ, Mesia-vela S, Basner C, Derk S, Henneberger P, Milton DK, Taveras B. Reproducibility and Validity of a Handheld Spirometer. Respir Care. 2008;53:433–41.PubMedPubMedCentral
19.
go back to reference Hallal PC, Muin A, Lopez MV, Valdivia G, Talamo C, Pertuze J. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America ˜. Eur Respir J. 2007;30:1180–5.CrossRefPubMed Hallal PC, Muin A, Lopez MV, Valdivia G, Talamo C, Pertuze J. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America ˜. Eur Respir J. 2007;30:1180–5.CrossRefPubMed
20.
go back to reference Carlsen HK, Gislason T, Benediktsdottir B, Kolbeinsson TB, Hauksdottir A, Thorsteinsson T, Briem H. A survey of early health effects of the Eyjafjallajökull 2010 eruption in Iceland : a population-based study. 2012. Carlsen HK, Gislason T, Benediktsdottir B, Kolbeinsson TB, Hauksdottir A, Thorsteinsson T, Briem H. A survey of early health effects of the Eyjafjallajökull 2010 eruption in Iceland : a population-based study. 2012.
21.
go back to reference Schirnhofer L, Firlei N. Using Targeted Spirometry to Reduce Non-Diagnosed Chronic Obstructive Pulmonary Disease. Respiration. 2011;81:476–82.CrossRefPubMed Schirnhofer L, Firlei N. Using Targeted Spirometry to Reduce Non-Diagnosed Chronic Obstructive Pulmonary Disease. Respiration. 2011;81:476–82.CrossRefPubMed
22.
go back to reference Knudsen TM, Mørkve ODD, Mfinanga S, Hardie JONA. Predictive equations for spirometric reference values in a healthy adult suburban population in Tanzania. Tanzan J Health Res. 2011;13:1–10. Knudsen TM, Mørkve ODD, Mfinanga S, Hardie JONA. Predictive equations for spirometric reference values in a healthy adult suburban population in Tanzania. Tanzan J Health Res. 2011;13:1–10.
23.
go back to reference Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.CrossRefPubMed Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.CrossRefPubMed
24.
go back to reference Chavasse R, Johnson P, Francis J, Balfour-Lynn I, Rosenthal M, Bush A. To clip or not to clip? Noseclips for spirometry. Eur Respir J. 2003;21:876–8.CrossRefPubMed Chavasse R, Johnson P, Francis J, Balfour-Lynn I, Rosenthal M, Bush A. To clip or not to clip? Noseclips for spirometry. Eur Respir J. 2003;21:876–8.CrossRefPubMed
25.
go back to reference Newall C, McCauley T, Shakespeare J, Cooper B. Is it necessary to use a noseclip in the performance of spirometry using a wedge bellows device? Chron Respir Dis. 2007;4:53–7.CrossRefPubMed Newall C, McCauley T, Shakespeare J, Cooper B. Is it necessary to use a noseclip in the performance of spirometry using a wedge bellows device? Chron Respir Dis. 2007;4:53–7.CrossRefPubMed
26.
go back to reference Ferguson G, Enright P, Buist A. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest. 2000;117:1146–61.CrossRefPubMed Ferguson G, Enright P, Buist A. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest. 2000;117:1146–61.CrossRefPubMed
27.
go back to reference Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163:1256–76.CrossRefPubMed Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163:1256–76.CrossRefPubMed
28.
go back to reference Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, Van Der Grinten CPM , Gustafsson P, Hankinson J, Jensen R, Johnson DC, Macintyre N, Mckay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–968.CrossRefPubMed Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, Van Der Grinten CPM , Gustafsson P, Hankinson J, Jensen R, Johnson DC, Macintyre N, Mckay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–968.CrossRefPubMed
29.
go back to reference Pasipanodya JG, Miller TL, Vecino M, Munguia G, Garmon R, Bae S, Drewyer G, Weis SE. Pulmonary impairment after tuberculosis. Chest. 2007;131:1817–24.CrossRefPubMed Pasipanodya JG, Miller TL, Vecino M, Munguia G, Garmon R, Bae S, Drewyer G, Weis SE. Pulmonary impairment after tuberculosis. Chest. 2007;131:1817–24.CrossRefPubMed
30.
go back to reference Lee JH, Chang JH. Lung function in patients with chronic airflow obstruction due to tuberculous destroyed lung. Respir Med. 2003;97:1237–42.CrossRefPubMed Lee JH, Chang JH. Lung function in patients with chronic airflow obstruction due to tuberculous destroyed lung. Respir Med. 2003;97:1237–42.CrossRefPubMed
31.
go back to reference Shoemark A, Ozerovitch L, Wilson R. Aetiology in adult patients with bronchiectasis. Respir Med. 2007;101:1163–70.CrossRefPubMed Shoemark A, Ozerovitch L, Wilson R. Aetiology in adult patients with bronchiectasis. Respir Med. 2007;101:1163–70.CrossRefPubMed
32.
go back to reference Konietzko NF, Carton RW, Leroy EP. Causes of death in patients with bronchiectasis. Am Rev Respir Dis. 1969;100:852–8.PubMed Konietzko NF, Carton RW, Leroy EP. Causes of death in patients with bronchiectasis. Am Rev Respir Dis. 1969;100:852–8.PubMed
33.
go back to reference Pasteur MC, Helliwell SM, Houghton SJ, Webb SC, Foweraker JE, Coulden RA, Flower CD, Bilton D, Keogan MT. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med. 2000;162(4 Pt 1):1277–84.CrossRefPubMed Pasteur MC, Helliwell SM, Houghton SJ, Webb SC, Foweraker JE, Coulden RA, Flower CD, Bilton D, Keogan MT. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med. 2000;162(4 Pt 1):1277–84.CrossRefPubMed
34.
go back to reference Nicotra MB, Rivera M, Dale AM, Shepherd R, Carter R. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest. 1995;108:955–61.CrossRefPubMed Nicotra MB, Rivera M, Dale AM, Shepherd R, Carter R. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest. 1995;108:955–61.CrossRefPubMed
35.
go back to reference Escombe AR, Moore DAJ, Gilman RH, Pan W, Navincopa M, Ticona E, Martínez C, Caviedes L, Sheen P, Gonzalez A, Noakes CJ, Friedland JS, Evans CA. The infectiousness of tuberculosis patients coinfected with HIV. PLoS Med. 2008;5:e188.CrossRefPubMedPubMedCentral Escombe AR, Moore DAJ, Gilman RH, Pan W, Navincopa M, Ticona E, Martínez C, Caviedes L, Sheen P, Gonzalez A, Noakes CJ, Friedland JS, Evans CA. The infectiousness of tuberculosis patients coinfected with HIV. PLoS Med. 2008;5:e188.CrossRefPubMedPubMedCentral
36.
go back to reference Calderon EJ, Rivero L, Respaldiza N, Morilla R, Montes-Cano MA, Friaza V, Munoz-Lobato F, Varela JM, Medrano FJ, de la Horra C. Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease Who Are Colonized with Pneumocystis jiroveci. Clin Infect Dis. 2007;45:e17–9.CrossRefPubMed Calderon EJ, Rivero L, Respaldiza N, Morilla R, Montes-Cano MA, Friaza V, Munoz-Lobato F, Varela JM, Medrano FJ, de la Horra C. Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease Who Are Colonized with Pneumocystis jiroveci. Clin Infect Dis. 2007;45:e17–9.CrossRefPubMed
37.
go back to reference Ehrlich RI, White N, Norman R, Laubscher R, Steyn K, Lombard C, Bradshaw D. Predictors of chronic bronchitis in South African adults. Int J Tuberc Lung Dis. 2004;8:369–76.PubMed Ehrlich RI, White N, Norman R, Laubscher R, Steyn K, Lombard C, Bradshaw D. Predictors of chronic bronchitis in South African adults. Int J Tuberc Lung Dis. 2004;8:369–76.PubMed
38.
go back to reference Caballero A, Torres-Duque CA, Jaramillo C, Bolívar F, Sanabria F, Osorio P, Orduz C Guevara DP, Maldonado D. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest. 2008;133:343–9.CrossRefPubMed Caballero A, Torres-Duque CA, Jaramillo C, Bolívar F, Sanabria F, Osorio P, Orduz C Guevara DP, Maldonado D. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest. 2008;133:343–9.CrossRefPubMed
39.
go back to reference Prescott E, Lange P, Vestbo J. Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. Eur Respir J. 1999;13:1109.CrossRefPubMed Prescott E, Lange P, Vestbo J. Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. Eur Respir J. 1999;13:1109.CrossRefPubMed
40.
go back to reference Rona RJ, Gulliford MC, Chinn S. Effects of prematurity and intrauterine growth on respiratory health and lung function in childhood. BMJ. 1993;306:817–20.CrossRefPubMedPubMedCentral Rona RJ, Gulliford MC, Chinn S. Effects of prematurity and intrauterine growth on respiratory health and lung function in childhood. BMJ. 1993;306:817–20.CrossRefPubMedPubMedCentral
41.
go back to reference National Bureau of Statistics: Tanzania in Figure 2014. Dar es Salaam. 2015. National Bureau of Statistics: Tanzania in Figure 2014. Dar es Salaam. 2015.
42.
go back to reference UNICEF. Children and Women in Tanzania. 2010. UNICEF. Children and Women in Tanzania. 2010.
43.
go back to reference Lee SW, Kim YS, Kim D-S, Oh Y-M, Lee S-D. The risk of obstructive lung disease by previous pulmonary tuberculosis in a country with intermediate burden of tuberculosis. J Korean Med Sci. 2011;26:268–73.CrossRefPubMedPubMedCentral Lee SW, Kim YS, Kim D-S, Oh Y-M, Lee S-D. The risk of obstructive lung disease by previous pulmonary tuberculosis in a country with intermediate burden of tuberculosis. J Korean Med Sci. 2011;26:268–73.CrossRefPubMedPubMedCentral
45.
go back to reference Swaminathan S, Narendran G, Menon PA, Padmapriyadarsini C, Arunkumar N, Sudharshanam NM, Kumar SR, Chandrasekhar S, Swaminathan S. Impact of HIV Infection on Radiographic Features in Patients with Pulmonary Tuberculosis. Indian J Chest Dis Allied Sci. 2007;49:133–6. Swaminathan S, Narendran G, Menon PA, Padmapriyadarsini C, Arunkumar N, Sudharshanam NM, Kumar SR, Chandrasekhar S, Swaminathan S. Impact of HIV Infection on Radiographic Features in Patients with Pulmonary Tuberculosis. Indian J Chest Dis Allied Sci. 2007;49:133–6.
46.
go back to reference Weis SE, Miller TL, Hilsenrath PE, Moonan PK. Comprehensive cost description of tuberculosis care. Int J Tuberc Lung Dis. 2005;9:467.PubMed Weis SE, Miller TL, Hilsenrath PE, Moonan PK. Comprehensive cost description of tuberculosis care. Int J Tuberc Lung Dis. 2005;9:467.PubMed
47.
go back to reference Miller TL, Reading JA, Hilsenrath P, Weis SE. What are the costs of suspected but not reported tuberculosis? Ann Epidemiol. 2006;16:777–81.CrossRefPubMed Miller TL, Reading JA, Hilsenrath P, Weis SE. What are the costs of suspected but not reported tuberculosis? Ann Epidemiol. 2006;16:777–81.CrossRefPubMed
48.
go back to reference Pasipanodya JG, McNabb SJ, Hilsenrath P, Bae S, Lykens K, Vecino E, Munguia G, Miller TL, Drewyer G, Weis SE. Pulmonary impairment after tuberculosis and its contribution to TB burden. BMC Public Health. 2010;10:259.CrossRefPubMedPubMedCentral Pasipanodya JG, McNabb SJ, Hilsenrath P, Bae S, Lykens K, Vecino E, Munguia G, Miller TL, Drewyer G, Weis SE. Pulmonary impairment after tuberculosis and its contribution to TB burden. BMC Public Health. 2010;10:259.CrossRefPubMedPubMedCentral
Metadata
Title
Lung functions among patients with pulmonary tuberculosis in Dar es Salaam – a cross-sectional study
Authors
Mohamed Manji
Grace Shayo
Simon Mamuya
Rose Mpembeni
Ahmed Jusabani
Ferdinand Mugusi
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2016
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-016-0213-5

Other articles of this Issue 1/2016

BMC Pulmonary Medicine 1/2016 Go to the issue